https://www.marketscreener.com/quote/stock/THORATEC-CORPORATION-11090/news/Thoratec-HeartMate-3-TM-CE-Mark-Trial-Meets-Primary-Endpoint-21104106/?utm_source=telegram&utm_medium=social&utm_campaign=share